SIS
AZN icon

Susquehanna International Securities’s AstraZeneca AZN Stock Holding History

Susquehanna International Securities’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-12,500
Closed -$1.37M – 47
2020
Q3 		$1.37M Buy
+12,500
New +$1.39M 0.72% 28
2019
Q3 		– Sell
-7,050
Closed -$582K – 93
2019
Q2 		$582K Buy
+7,050
New +$553K 0.19% 66

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Securities's AZN Position: Q3 2024 in Review

Susquehanna International Securities opened a new position in AstraZeneca (AZN) in Q3 2024: 6,116 shares worth $953K. The stake represents 0.23% of the portfolio and ranks #30 among its holdings. This is a return to the name: Susquehanna International Securities previously reported a position in AZN as recently as Q1 2024.

Susquehanna International Securities first reported a position in AZN in Q4 2018 and has held it in 14 quarters since. The position peaked at $13.7M in Q4 2020. 1,230 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

  • Susquehanna International Securities held 6,116 shares of AstraZeneca worth $953K as of Q3 2024.
  • AstraZeneca was a new Susquehanna International Securities position in Q3 2024.
  • AstraZeneca made up 0.23% of Susquehanna International Securities's portfolio in Q3 2024, its #30 holding.
  • Susquehanna International Securities first reported a position in AstraZeneca in Q4 2018 and has held it in 14 quarters since.
  • Susquehanna International Securities's AstraZeneca position peaked at $13.7M in Q4 2020.
  • 1,230 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on Susquehanna International Securities's 13F filing for Q3 2024, filed 14 Nov 2024.